The combined solutions will allow for a more thorough risk mitigation strategy, including real-time claims reporting. This ground-breaking combination is going to change the way the insurance industry operates within the transportation sector.

PURCELLVILLE, Va. (PRWEB)
May 05, 2020

ClearConnect Solutions Group, LLC, a leader in assisting the transportation and insurance industries with the management of risk, partners with Matrix Telematics to provide a unique risk mitigation technology that will help the transportation and insurance industries proactively reduce claims, losses and costs.

Matrix Telematics delivers innovative telematics solutions to fleet operators across the UK, Europe and beyond by processing data intelligently for almost 100,000 vehicles.

“Matrix Telematics has an excellent, easy-to-use product with a tremendous amount of experience, which are values we were looking for in a telematics partner,” states Scott A. Grandys, President, ClearConnect Solutions Group, LLC. Scott adds, “We are excited about the combined value ClearTrac and Matrix Telematics will offer to the transportation and insurance industries. The combined solutions will allow for a more thorough risk mitigation strategy, including real-time claims reporting. This ground-breaking combination is going to change the way the insurance industry operates within the transportation sector.”

“Combining our state-of-the-art, easy to use technology with the ClearTrac system will provide an exciting opportunity for both our companies,” comments Phil Powell, Sales Director, Matrix Telematics. “We are excited to take our experience from the UK and European markets to the United States through our partnership with ClearConnect Solutions Group, LLC and their experience in the insurance industry. Our goal is to duplicate our safety and cost saving results in the US by teaching transportation fleets and insurers how to properly leverage telematics to reduce their operating expenses, loss ratios and claims expenditures,” Phil continues.

Mark Packman, Chief Executive Officer of Matrix Telematics remarked, “When Wayne and I founded Matrix Telematics in 2001 our goal was to take our 50+ years of experience in this space and develop cutting edge telematics based products to include features such as: crash detection, fuel expenditure, tire monitoring, driver risk scoring, and a wide-range of camera options. ClearConnect Solutions Group, LLC is a great partner fit because both of our companies are searching to accomplish the same goal for the transportation and insurance industries. Finalizing this deal was easy because of our common business interests and we are excited about bringing our product and service to the United States through the ClearTrac Network,” adds Mark.

For more information about ClearConnect Solutions Group, LLC, please visit their website at http://www.clearconnectsolutions.com

For more information about Matrix Telematics, please visit their website at http://www.matrixtelematics.com

Share article on social media or email:

Aluminum Shapes Drive Through Testing Shelter

“Solomon and his team at Aluminum Shapes have helped us develop the essential structures for our mobile testing sites which are vital to combating this virus.”

PENNSAUKEN, N.J. (PRWEB)
May 05, 2020

Through a partnership with George Norcross of Connor Strong & Buckelew and Camden County Freeholder Director Louis Cappelli, Jr, Aluminum Shapes LLC, based in Pennsauken NJ, has donated a large drive through testing center for use at Camden County’s highest volume test site at 2600 Mt Ephraim ave.

“The generosity and thoughtfulness of this donation from Aluminum Shapes is a textbook example of our corporate citizens stepping up to the plate in the hour of our need,” Freeholder Director Louis Cappelli Jr. said. “Solomon and his team at Aluminum Shapes have helped us develop the essential structures for our mobile testing sites which are vital to combating this virus. I want to thank them for their commitment to our community and to their dedication to helping us respond to the pandemic.”

The semi-permanent structure measures 16’x 36’ and replaces the tents formerly used. “Our Drive-Through Shelters were designed to provide a safe, sterile, and secure place for the hard working healthcare workers who need to operate in a dangerous environment every day,” said Solomon Rosenthal, CEO of Aluminum Shapes.

“When we saw the environment those on the front lines were working in, we realized that we could improve on it, especially after seeing reports of tents blowing over, collapsing, and injuring people. Our entire workforce was energized as we re-tooled to produce these shelters. It’s our way of helping the world around us while keeping our employees working. We take tremendous pride in knowing we are helping others and making a real difference,” continued Rosenthal.

Aluminum Shapes is providing a number of drive through test sites and shelters to local governments as well as renting them at a discounted rate to assist in the COVID-19 response nationwide.

The shelters and test sites are designed, fabricated and assembled in Pennsauken, NJ. They are built completely out of Aluminum, harbor the COVID-19 virus for the least amount of time of any building material, are easily sterilized, and are 100% recyclable.

Inquires and requests for more information should be sent to Shelters@shapesllc.com.

Share article on social media or email:

Journal of Oral Implantology Volume 46 Issue 2

The clinicians also reviewed the many complications associated with Marfan syndrome. In doing so, they highlighted that dental professionals should become familiar with the oral manifestations of this syndrome to help patients improve their quality of life through prevention and management.

LAWRENCE, Kan. (PRWEB)
May 05, 2020

Journal of Oral Implantology – Marfan syndrome is a genetic disorder that affects connective tissue throughout the body and causes many clinical manifestations in patients. One such common complication is advanced gum disease that increases the risk for mitral valve prolapse and damage the aorta, bones, eyes, lungs, and covering of the spinal cord. A recent case report in the Journal of Oral Implantology details a viable treatment option for a Marfan syndrome patient with jawbone loss and misaligned teeth.

Clinicians from the University of Kentucky and the University of Aberdeen cared for a 56-year-old Marfan syndrome patient who had a long and complex oral treatment history. However, as a result of advanced gum disease, bone loss continued to progress, and the patient sought a full-mouth dental replacement. First, dentists performed a sinus lift with a bone graft to augment the upper jawbone that had lost volume and density; without it, there would not have been enough bone to support dental implants. After a healing period of 9 months, clinicians extracted all remaining teeth and examined the quality of the bone graft, noting that the outcome was positive.

Nine SLActive screw-like implants were placed in the lower and upper jaw ridges, where teeth are normally. Then, after the implants integrated with the jaw bones—called osseointegration— locator abutments were installed, which are above-the-gum attachment pieces that allow the patient to easily insert a removable dental prosthesis. Finally, the dental prosthesis was constructed, fitted and provided to the patient. The patient was seen for follow-up appointments for 2 years, and the clinicians noted that the patient was pleased with the result and had no problems with the removable dental prosthesis.

The clinicians also reviewed the many complications associated with Marfan syndrome. In doing so, they highlighted that dental professionals should become familiar with the oral manifestations of this syndrome to help patients improve their quality of life through prevention and management. The authors conclude that their technique is an excellent option for patients with Marfan syndrome who need a dental prostheses.

Full text of the article “Full-Mouth Rehabilitation with Implant-Prosthesis in Marfan Syndrome Patient: Clinical Report and Literature Review” in the Journal of Oral Implantology is available at https://doi.org/10.1563/aaid-joi-D-19-00151.

About the Journal of Oral Implantology

The Journal of Oral Implantology is the official publication of the American Academy of Implant Dentistry and the American Academy of Implant Prosthodontics. It is dedicated to providing valuable information to general dentists, oral surgeons, prosthodontists, periodontists, scientists, clinicians, laboratory owners and technicians, manufacturers, and educators. The JOI distinguishes itself as the first and oldest journal in the world devoted exclusively to implant dentistry. For more information about the journal or the society, please visit http://www.joionline.org

Media Contact:

Dominique Scanlan

Allen Press, Inc.

800/627-0326 ext. 226

dscanlan@allenpress.com

Share article on social media or email:

BCEN’s Trauma Certified Registered Nurse (TCRN) credential is held by over 5,200 trauma and emergency care nurses.

“Whether she is delivering life-saving trauma care, encouraging her peers to advance themselves and their practice through certification, or teaching weekly classes on trauma topics, Lt. Pruett’s dedication to trauma care excellence is remarkable.”

OAK BROOK, Ill. (PRWEB)
May 05, 2020

The Board of Certification for Emergency Nursing (BCEN), the benchmark for board certification across the emergency nursing spectrum, announced today that U.S. Air Force emergency services/trauma nurse First Lieutenant Mariah Pruett, NC, BSN, RN, CEN, CFRN, CPEN, TCRN, CCRN, from the 60th Medical Group/Emergency Services Flight at David Grant USAF Medical Center, Travis Air Force Base, California, is the recipient of BCEN’s 2020 Distinguished TCRN Award. Travis AFB is home to the state-of-the-art David Grant USAF Medical Center (DGMC), which provides a full spectrum of care to more than 130,000 TRICARE eligible patients in the San Francisco/Sacramento area and 500,000 Northern California veterans.

Each year, BCEN recognizes one top Trauma Certified Registered Nurse (TCRN) who demonstrates an exceptional commitment to certified trauma nursing excellence while advocating for others to earn trauma nursing’s highest professional credential. The over 5,200 nurses who hold the TCRN have demonstrated advanced knowledge, expertise and clinical judgment across the trauma care continuum, from injury prevention and prehospital care, to acute care, to rehabilitation and reintegration into society.

“Whether she is delivering life-saving trauma care and stabilization for U.S. and Allied forces while on deployment, encouraging her peers to advance themselves and their trauma nursing practice through certification, or teaching weekly classes on trauma topics to over 100 special operations medics and paramedics, Lt. Pruett’s dedication to trauma care excellence is remarkable,” said BCEN Executive Director Janie Schumaker, MBA, BSN, RN, CEN, CENP, CPHQ, FABC.

After earning the TCRN credential plus BCEN specialty certifications in flight nursing and pediatric emergency nursing in the same year, Pruett designed a mentorship program that increased the TCRN certification rate in the 60th Medical Group by 200%. Pruett also trained to serve on Critical Care Air Transportation Team (CCATT) and Tactical Critical Care Evacuation Team (TCCET) missions.

“Lt. Pruett has constantly let her achievements in patient care and certification shine as a bright example for those around her to follow,” said Major Michael C. Galante, DGMC Emergency Services Medical Director. “She continually strives for excellence in both her clinical knowledge and clinical care, elevating the knowledge and skill of those around her by doing so.”

“Becoming a Trauma Certified Registered Nurse has been a goal of mine since I first stepped foot into an emergency department,” said Pruett. “Earning this award shows how far I have come in my career, from a new nurse hungry to learn, to a skilled nurse running trauma bays, taking care of in-flight trauma, and advocating for my colleagues to earn their own certifications. It is an honor to receive BCEN’s Distinguished TCRN Award.”

Read more about Lt. Pruett at https://bcen.org/2020-tcrn-award-winner/

BCEN’s Annual Nurse and Organizational Awards

The winner of this year’s Distinguished TCRN Award was determined by a selection committee consisting of BCEN board members, staff and volunteer subject matter experts as well as a Society of Trauma Nurses (STN) official. BCEN is grateful for STN’s partnership in promoting the annual nomination process and sponsoring past winners’ travel to the awards presentation ceremonies. Due to the COVID-19 pandemic, the in-person presentation of the 2020 Distinguished TCRN Award is to be determined.

Every year, BCEN recognizes individual specialty certified emergency, trauma and transport nurses as well as hospitals and health systems that demonstrate and advance certified nursing excellence and advocate for emergency nurse board certification. Learn more about BCEN’s Distinguished Awards and National Certification Champion Awards at bcen.org/awards.

About BCEN

Throughout 2020, the independent, not-for-profit Board of Certification for Emergency Nursing (BCEN®) is celebrating 40 years of robust certification programs fostering empowered nurses across the emergency spectrum who contribute noticeably to patient care, safety and outcomes. Over 55,000 BCEN board certifications are currently held by registered nurses (RNs) who specialize in emergency, flight, critical care ground transport, pediatric emergency and trauma nursing. BCEN offers the Certified Emergency Nurse (CEN®), Certified Flight Registered Nurse (CFRN®), Certified Pediatric Emergency Nurse (CPEN®), Certified Transport Registered Nurse (CTRN®) and Trauma Certified Registered Nurse (TCRN®) certifications. The CEN, CFRN, CPEN, and TCRN certification programs are accredited by the Accreditation Board for Specialty Nursing Certification (ABSNC). Learn more at bcen.org. Follow BCEN on Facebook, LinkedIn and Instagram.

Share article on social media or email:

The Salimetrics Total IgM Assay Kit quantifies levels of total human IgM in saliva and other oral fluids, which can be used for sample quality assurance and as inclusion criteria when using oral fluid as an alternative sample type for serological studies.

STATE COLLEGE, Pa. (PRWEB)
May 05, 2020

As the world adapts to the evolution of the COVID-19 pandemic, infectious disease epidemiologists and public health officials need tools to enable surveillance at scale. More so than ever, our need to understand who has and who hasn’t been exposed seems paramount. This is especially true when some individuals who have been exposed express disease symptoms while others do not. Research is needed to decipher how to interpret what “exposure without symptoms” means in terms of individual and public health in the short and longer term.

Saliva and oral fluids provide investigators and public health officials a minimally invasive means of obtaining biospecimens at scale. Studies show that saliva collection is preferred over more traditional biospecimen collection protocols (e.g., venipuncture, finger stick, nasopharyngeal swab) and that samples can be self-collected here, there, and almost everywhere with minimal training. In an effort to advance the science, Salimetrics introduces a new ELISA Kit to measure human total Immunoglobulin M (IgM) in saliva and oral fluids.

The Salimetrics Total IgM Assay Kit quantifies levels of total human IgM in saliva and other oral fluids, which can be used for sample quality assurance and as inclusion criteria when using oral fluid as an alternative sample type for serological studies. Pathogen specific IgM is indicative of recent acute exposure, and when used together with total IgM, researchers can confidently track outbreak scenarios and minimize false negatives due to inadequate total IgM levels using the convenience of oral fluid sampling.

Immunoglobulin M (IgM) is present in two major forms in the circulation. Natural IgM is a low-affinity pentameric molecule that binds to invading pathogens without requiring prior exposure. This form acts to directly neutralize viruses, activate complement, trigger phagocytosis, and drive antibody dependent cell mediated cytotoxicity. Adaptive IgM is the first antibody produced in response to invading pathogens and functions in a similar way to natural IgM but is a high-affinity molecule. The majority of IgM is pentameric and includes the J chain which is also a key structural component found in polymeric IgA. IgM also naturally forms hexamers, however, in this case the J chain is absent.

In serology studies, the detection of pathogen specific IgM is often used as an indication of recent exposure and has more utility as a marker during an infectious disease outbreak. The major source of IgM in oral fluid is serum leaking from the gingiva. For salivary measures of pathogen specific IgM, total IgM should be used to qualify the salivary sample to ensure there are adequate levels of total IgM to detect the disease specific IgM of interest.

The Salimetrics Total Salivary IgM Assay Kit features a small test volume of 10 µL, dynamic range of 0.39 – 25 ng/mL, lower limit of detection of 0.03 ng/mL, and average inter and intra-assay coefficients of variation less than 10%. The assay is provided in a standard 96-well plate format for single use and is also available in bulk packaging for high-throughput applications. The new salivary IgM assay takes its place alongside the recently released Salimetrics Salivary Total Human IgG Assay Kit. Together, these assays assure the quality of oral fluid/saliva samples and therefore improve specificity and sensitivity of corresponding pathogen specific serological assays. Saliva collection has been validated with SalivaBio’s oral fluid/saliva collection protocols and follows the same convenient and reproducible methods that SalivaBio has provided the scientific community for years.

Salimetrics is a key partner in best-in-class solutions to salivary bioscience research. By using Salimetrics products and services, researchers can experience solutions to problems where the full potential of salivary measures have yet to be realized. To learn more about the new Salivary IgM Assay Kit, researchers can visit the Salimetrics Website, or contact expert researcher support to integrate salivary IgM into their current or future research study.

About Salimetrics

Salimetrics’ assay kits and CLIA-certified testing services are used to measure salivary analytes related to stress, behavior and development, inflammation, sleep, reproduction, health and immune function. Founded in 1998 by Douglas A. Granger, Ph.D., Salimetrics, LLC support CROs, pharmaceuticals, academic researchers and the immunodiagnostic industry around the world with innovative immunoassay products, non-invasive saliva collection methods, and laboratory testing services.

Share article on social media or email:

Drs. Nabil Fehmi and Maryam Beyramian Raise Awareness of Juvenile Arthritis in Phoenix, AZ

Patients seeking pediatric care can be seen by both a medical doctor and a dentist at the same location and frequently within the same day.

PHOENIX (PRWEB)
May 05, 2020

Westwind Integrated Health is spreading awareness of juvenile arthritis and how it affects nearly 300,000 children in the United States. Children who suffer from juvenile idiopathic arthritis (JIA) can experience temporomandibular joint (TMJ) pain affecting their jaw, along with overall swelling or stiffness of the joints. Westwind Integrated Health specializes in both dental and medical treatment, so children suffering from juvenile arthritis in Phoenix, AZ can receive comprehensive pediatric care from this versatile practice.

Juvenile arthritis is an inflammatory condition or pediatric rheumatic disease that can develop in children under the age of 16, regardless of ethnic background or age. Juvenile arthritis is treatable, and children affected can live normal lives. Common causes and symptoms of juvenile arthritis include:

• Genetic predisposition to arthritis
• Joint pain, swelling, redness or warmth
• Swollen or sore eyes, skin, muscles or gastrointestinal tract

Children with juvenile arthritis are more at risk of inflamed gum tissue and of being diagnosed with gum disease. It has also been found that these children can suffer from pain in the temporomandibular joint or muscle. Those with TMJ disorder may experience stiffness in the jaw, which impedes normal oral function. Additional dental concerns include jaws growing at different speeds or difficulty in brushing and flossing teeth.

Westwind Integrated Health offers full-service medical and dental care at their unique practice. Patients seeking pediatric care can be seen by both a medical doctor and a dentist at the same location and frequently within the same day. This multi-specialty approach allows doctors and patients to look at the whole body, not just one specific area at a time. Since the mouth and body are so interconnected, this integration allows the doctors of Westwind Integrated Health to give patients a comprehensive full-body approach to healthcare.

“Unless we have a healthy body, we can never have a healthy mouth. We start with the mouth, then go to the body, then back to the mouth and back to the body in order to make sure everything is healthy at the same level,” says Dr. Maryam Beyramian.

With timely and effective TMJ treatment and treatments for overall juvenile arthritis, children can see vast improvements in their day-to-day lives. The doctors at Westwind Integrated Health advise parents to not let their children neglect their oral health and to schedule dental exams every six months.

Those interested in learning more about juvenile arthritis or who would like to receive integrated pediatric care in Phoenix, AZ are encouraged to schedule an appointment at Westwind Integrated Health. Appointments can be made by calling 602-457-8024. More information can also be found online at http://www.westwindintegratedhealth.com.

About the Practice

Westwind Integrated Health offers dental and medical care from nine locations in the Glendale and Phoenix, AZ areas. As the only private practice in Arizona and one of only a few practices in the country to combine dental and medical care, this team is innovating health care by offering truly comprehensive care with a whole-body approach. Comprised of a multi-disciplinary team of medical doctors and dental clinicians, Westwind Integrated Health offers specialized general dentistry, orthodontics, endodontics, periodontics, oral and maxillofacial surgery. Plus, under the same roof, patients can receive physicals and wellness exams, vision and hearing screenings, vaccinations, nutritional counseling, and minor injury treatment. The family of practices focuses on building genuine patient relationships, comprehensive and state-of-the-art treatment, and improving the long-term health and wellbeing of their patients. To learn more about the multi-specialty team, visit http://www.westwindintegratedhealth.com or call 602-457-8024 to schedule an integrated health consultation.

Share article on social media or email:

Opendock

“It feels good to know that our software is playing a key role in helping to successfully overcome this pandemic. And being able to get PPE to those who need it most is a critical component.”

SCOTTSDALE, Ariz. (PRWEB)
May 05, 2020

Warehouses and distribution centers that move healthcare-related products are facing serious challenges due to the pandemic. Most were not prepared for the massive surge in volume.

While the difficulty in manufacturing and distribution for household paper products has been problematic, challenges in getting PPE (personal protective equipment) to healthcare workers is a matter of life and death. Indeed, hospital staff and other front-line workers require PPE to properly and safely perform their jobs.

PPE includes medical masks, goggles, clothing, gloves, and other protective gear used by healthcare workers and other first responders. In some cases, getting PPE to those who need it has been a manufacturing problem – the items simply are not available. In other instances, the snag has been with distribution.

Part of the difficulty with distribution during the pandemic has been that warehouses and distribution centers are not well-equipped to handle huge spikes in volume. One reason is that warehouses have a fixed number of dock doors. Even if a given warehouse has additional storage capacity, it can only serve a limited number of trucks at one time. This has created a logjam that has plagued thousands of warehouse facilities as a result of the pandemic.

But a specified number of dock doors is just one of the problems warehouses and DCs are facing.

Because many warehouses have extended their hours to help with the demand, they are being stretched thin on staffing. They are asking more of their existing team members while trying to quickly onboard new staff.

Additionally, the carriers who deliver to and pick up from warehouses are feeling some pain. A large food distributor recently reported lines of trucks of up to two miles and wait times spanning days. Many of the trucks were bringing goods to the warehouse. But a large number of them were waiting to be loaded so they could transport the food products to other DCs or to stores.

While the chaos has been nearly unbearable for many warehouses, others are smoothly handling this throughput challenge by utilizing dock scheduling software, such as Opendock.

Lawrence Dillworth, inbound supervisor at Owens & Minor, noted, “Without Opendock during the COVID-19 volume surge, it would have been a catastrophic failure.” Owens & Minor is a $9 billion manufacturer and distributor of healthcare products.

Opendock allows carriers to book specific appointment times to load or unload freight, solving many of the problems associated with the historical first come, first served model. In that model, trucks compete to get in line as early as possible to minimize their wait time. It’s an inefficient model for both truckers and warehouses.

Opendock CEO, Bob La Loggia, said, “It feels good to know that our software is playing a key role in helping to successfully overcome this pandemic. And being able to get PPE to those who need it most is a critical component.”

Opendock is based in Scottsdale, Arizona. It is a centralized shipping dock scheduling platform that allows carriers and brokers to book appointments with warehouses. With over 25,000 registered users, all major carriers and brokers use the platform daily, including C.H. Robinson, Echo, Schneider, XPO, DHL, and Estes. Additionally, some of the largest shippers in the world also use the system, such as Cargill, Ecolab, International Paper, Pepsi, and others. To learn more about Opendock, click here.

Share article on social media or email:

NATSARS(COV2)-ERC
NATtrol SARS-CoV-2 Positive Quality Control

“Due to the unprecedented COVID-19 pandemic, we were tasked to develop and deploy reliable, user-friendly commercial solutions for ready-to-use, non-infectious SARS-CoV-2 full process molecular quality controls under accelerated timelines.”

BUFFALO, N.Y. (PRWEB)
May 05, 2020

Continuing in its efforts to rapidly respond to today’s COVID-19 pandemic, ZeptoMetrix Corporation (ZMC) announced today the development and release of a ready-to-use SARS-CoV-2 molecular quality control formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable:

• 
      NATtrol SARS-CoV-2 Positive Control
•     Product Number: NATSARS(COV2)-ERC

Complementing the release of the positive control is a negative control formulated with human A549 cells:

•     NATtrol SARS-CoV-2 Negative Control
•     Product Number: NATSARS(COV2)-NEG

“Due to the unprecedented COVID-19 pandemic, we were tasked to develop and deploy reliable, user-friendly commercial solutions for ready-to-use, non-infectious SARS-CoV-2 full process molecular quality controls under accelerated timelines. Today, I am extremely proud to announce that ZeptoMetrix has launched such controls – containing purified intact viral particles of actual SARS-CoV-2 that provide laboratories, hospitals and research facilities with essential external run controls to help ensure the reliability of COVID-19 testing”, explains Shawn R. Smith, President & CEO of ZeptoMetrix.

“In conjunction with our existing and ever expanding product portfolio, we recognize the responsibility embodied by our company’s ability to meet today’s challenges and to positively impact public health efforts by leveraging the many capabilities we possess. From initial sourcing of the virus to carefully controlled processing in containment labs and through the array of technical, operational and logistical resources deployed against this endeavor, our company rose to the challenge by displaying the commitment and perseverance required to succeed, especially in these challenging times.”

Today more than ever, it is critical to global healthcare that we have a more complete understanding of Infectious Diseases and the diagnostic technologies employed in their testing. ZeptoMetrix has enhanced its coronavirus product line and has made it a priority to ensure product availability to diagnostic companies developing new and improved tests as well as those laboratories in hospitals and clinics seeking to ensure the reliability of the tests they perform.

ZEPTOMETRIX CORONAVIRUS PRODUCTS:

SARS-CoV-2

NATtrol SARS-CoV-2 Positive Control – NATSARS(COV2)-ERC

NATtrol SARS-CoV-2 Negative Control – NATSARS(COV2)-NEG

NATtrol SARS-CoV-2 Stock – NATSARS(COV2)-ST

SARS-CoV-2 Isolate: USA-WA1/2020 Heat Inactivated Culture Fluid – 0810587CFHI-0.5ML

SARS-CoV-2 Isolate: USA-WA1/2020 Heat Inactivated Culture Fluid – 0810587CFHI

SARS-CoV-2 Recombinant

NATtrol SARS-CoV-2 (recombinant) Stock – 0831042

NATtrol SARS-CoV-2 (E/ORF1ab recombinant) Stock – 0831043

SARS 2003-00592

NATtrol Coronavirus SARS Stock – NATSARS-ST

Coronavirus 229E

NATtrol Coronavirus 229E Stock – NATCOV(229E)-ST

Coronavirus Strain: 229E Culture Fluid – 0810229CF

Coronavirus Strain: 229E Heat Inactivated Culture Fluid – 0810229CFHI

Coronavirus Strain: 229E Lysate – 0810229

Coronavirus NL63

NATtrol Coronavirus NL63 Stock – NATCOV(NL63)-ST

Coronavirus Strain: NL63 Culture Fluid – 0810228CF

Coronavirus Strain: NL63 Heat Inactivated Culture Fluid – 0810228CFHI

Coronavirus Strain: NL63 Lysate – 0810228

Coronavirus OC43

NATtrol Coronavirus OC43 Stock – NATCOV(OC43)-ST

Coronavirus Strain: OC43 Culture Fluid – 0810024CF

Coronavirus Strain: OC43 Heat Inactivated Culture Fluid – 0810024CFHI

Coronavirus Strain: OC43 Lysate – 0810024

MERS-CoV Florida/USA-2_Saudi Arabia_2014

NATtrol MERS-CoV Stock – NATMERS-ST

MERS-CoV Strain: Florida/USA-2_Saudi Arabia_2014 Culture Fluid – 0810575CF

MERS-CoV Strain: Florida/USA-2_Saudi Arabia_2014 Heat Inactivated Culture Fluid – 0810575CFHI

About ZeptoMetrix®

ZeptoMetrix Corporation (ZMC) is an established industry leader in the design, development, and delivery of innovative, quality solutions to the Infectious Disease Diagnostics Market. Our expertise and abilities in Molecular Diagnostics, including External Quality Controls, Verification Panels, Proficiency Panels, Customized and OEM Products/Services have set the industry standard for performance and reliability and made ZeptoMetrix the preferred choice for independent 3rd party QC materials.

Founded in 1999, ZeptoMetrix is headquartered in Buffalo, NY with additional facilities in Franklin, Massachusetts.

About NATtrol™

Globally, millions of people are tested for infectious diseases each year. The implications of reporting either a false positive or a false negative can be devastating to the patient. Accurate and sensitive diagnostics are necessary to confirm that laboratories are providing patients with proper testing results. Utilizing ZeptoMetrix NATtrol QC materials on a consistent basis helps to monitor testing performance and enhance confidence in testing results.

ZeptoMetrix NATtrol Molecular Diagnostics products are an essential component of today’s ever-evolving testing market and are designed to provide safe, accurate and cost-effective support for activities relating to the analysis and identification of possible disease-causing microorganisms. The patented ZeptoMetrix NATtrol process renders highly-purified microorganisms non-infectious while allowing internal nucleic acids to remain intact, thereby serving as an ideal reference material for molecular diagnostic testing applications. Representing a total process control, from DNA extraction through amplification and eventual detection, NATtrol products are ready-to-use, refrigerator stable, and safe for operators to handle.

The routine and repetitive use of NATtrol™ External Run Controls and Verification Panels help enable laboratories to monitor performance and identify trends in daily test variations, test kit lot changes, and among individual operators.

For Sales and/or information regarding ZeptoMetrix, NATtrol Molecular Quality Controls & Panels, and Development/Custom Services, please contact ZeptoMetrix Customer Service.

Contact:

ZeptoMetrix Corporation, Customer Service

878 Main Street

Buffalo, NY 14202

716-882-0920

custserv@zeptometrix.com

Media:

Michael Hershfield, Vice President, Sales & Marketing

508-553-5852

mhershfield@zeptometrix.com

Share article on social media or email: